Affimed Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Shawn Leland

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure7.3yrs
Board average tenure9.5yrs

Recent management updates

Recent updates


CEO

Shawn Leland (40 yo)

less than a year

Tenure

Dr. Shawn M. Leland, Pharm.D. R.Ph. serves as Chief Executive Officer at Afirmed N.V. from September, 2024. He was Interim Chief Executive Officer and Director of Fore Biotherapeutics Inc. since September...


Leadership Team

NamePositionTenureCompensationOwnership
Wolfgang Fischer
MD, COO & Member of Management Board7.3yrs€1.26m0.89%
$ 187.7k
Denise Mueller
Chief Business Officer & Member of Management Board3.5yrs€1.17m0.55%
$ 115.9k
Andreas Harstrick
Chief Medical Officer & Member of Management Boardno data€1.14m0.46%
$ 98.1k
Shawn Leland
Chief Executive Officerless than a yearno datano data
Melvyn Little
Founder & Consultant24.9yrsno datano data
Michael Wolf
Head of Finance & Administration9.9yrsno datano data
Alexander Fudukidis
Head of Investor Relations & Director of Investor Relationsno datano datano data
Mary Sandin
Vice President of Marketing & Communicationsno datano datano data

7.3yrs

Average Tenure

57yo

Average Age

Experienced Management: 0HL9's management team is seasoned and experienced (7.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Miroslav Ravic
Member of Scientific Advisory Boardno datano datano data
Thomas Hecht
Independent Chairman of Supervisory Board17.9yrs€162.00k0.24%
$ 49.7k
Owen O'Connor
Member of Scientific Advisory Board9.5yrsno datano data
Susanne Becker
Member of Scientific Advisory Boardno datano datano data
Andreas Engert
Member of Scientific Advisory Boardno datano datano data
Max Topp
Member of Scientific Advisory Boardno datano datano data
Christian Hucke
Member of Scientific Advisory Boardno datano datano data
Anton Hagenbeek
Member of Scientific Advisory Boardno datano datano data
Franck Morschhauser
Member of Scientific Advisory Boardno datano datano data
Ulrike Köhl
Member of Scientific Advisory Boardno datano datano data
Stephen Ansell
Member of Scientific Advisory Board9.5yrsno datano data
Andrew Evens
Member of Scientific Advisory Board8.9yrsno datano data

9.5yrs

Average Tenure

Experienced Board: 0HL9's board of directors are considered experienced (9.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 18:47
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Affimed N.V. is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James BirchenoughBMO Capital Markets Equity Research
Li Wang WatsekCantor Fitzgerald & Co.
Bradley CaninoCredit Suisse